RE: Quick question8 Mar 2022 22:54
I've been in since 2011 - the raw potential of the two projects in the portfolio have significant upside, especially given the current MCAP of around £2.5m - but, personally, I see this stock now as a raw punt.
We're technically *only* pending an exploitation permit in Togo, and that alone could see us valued up around 0.5p on the conservative side, with upside as the project progresses to Phase 2. However, that permit is proving highly elusive, and there's rightly some scepticism that the Togolese President is hoping we'll bleed out, so he can put the project into the hand of people he prefers.
The Phosphate play has potential to be a steady income generator for 60 years with upside, but we are in a dispute situation with the co-owner that has currently led to the operation working to 'special measures' until its resolved. Terrible timing, given the global macroeconomic situation. Similar to Togo, it's one of those situations that could be resolved and see the share price grow in multiples, or it could lead to protracted and costly legal proceedings.
If I were to sum it up, I'd say it's an all or nothing, boom or bust share. Personally, I'd be really cautious about putting any more money in as it stands - I've made my money off a divested gold project that the BoD set up within Keras and spun out, so I'm prepared to sit and wait - but these are very much in the bottom drawer.
Best of luck with what ever you decide. We're a nice bunch here, so I'm sure you'll get some more views.